Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Outcomes of Primary Bone Diffuse Large B-Cell Lymphoma in the Rituximab Era: A Multicenter Retrospective Analysis

Blood (2021) 138 (Supplement 1): 1451.

https://doi.org/10.1182/blood-2021-145145

Published: 2021

Journal Articles

Quality of Life in Patients <=70 Years of Age with Chronic Lymphocytic Leukemia Treated Frontline with Ibrutinib-Rituximab Versus Fludarabine Cyclophosphamide Rituximab: Analysis from ECOG-ACRIN E1912

Blood (2021) 138 (Supplement 1): 1562.

https://doi.org/10.1182/blood-2021-150462

Published: 2021

Journal Articles

Results from the Phase 3 DUO TM Trial: A Randomized Comparison of Duvelisib Vs Ofatumumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Blood (2017) 130 (Supplement 1): 493.

https://doi.org/10.1182/blood.V130.Suppl_1.493.493

Published: 2017

Journal Articles

A Phase 2 Multicenter Study of Continuous Dose Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Todd A. Fehniger, MD/PhD, Sarah Larson, Kathryn Trinkaus, PhD, Marilyn J. Siegel, MD, David D. Hurd, MD, Kristie A. Blum, MD, Andre Goy, MD, Timothy S. Fenske, MD, Amanda Cashen, MD, Nina D. Wagner-Johnston, MD, Kenneth R. Carson, MD, Nancy L. Bartlett, MD

Blood (2012) 120 (21): 1623.

https://doi.org/10.1182/blood.V120.21.1623.1623

Published: 2012

Journal Articles

Defining the Malignant Epigenome in Non-Hodgkin Lymphoma

Jacqueline E. Payton, MD, PhD, Olivia I. Koues, PhD, Rodney Kowalewski, BS, Jennifer A. Schmidt, MS, Li-Wei Chang, PhD, Amanda Cashen, MD, Nancy L. Bartlett, MD, Eugene M. Oltz, PhD

Blood (2012) 120 (21): 524.

https://doi.org/10.1182/blood.V120.21.524.524

Published: 2012

Journal Articles

Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older with Acute Myeloid Leukemia,

Meagan A Jacoby, MD/PhD, Michael Martin, Teresa Reineck, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Amanda Cashen, MD, Keith Stockerl-Goldstein, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Camille N. Abboud, MD

Blood (2011) 118 (21): 3633.

https://doi.org/10.1182/blood.V118.21.3633.3633

Published: 2011

Journal Articles

Phase I Study of Cladribine (2-chlorodeoxyadenosie), Cytarabine and G-CSF Based Induction Therapy (CLAG) with ATRA (All-trans retinoic acid) and Midostaurin for Relapsed/Refractory AML,

Giridharan Ramsingh, MD, Andrew Sprau, M.S, Peter Westervelt, MD, PhD, Ali McBride, PharmD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MD, Geoffrey L. Uy, MD, Amanda Cashen, MD, John F. DiPersio, MD, PhD, Camille N. Abboud, MD

Blood (2011) 118 (21): 3609.

https://doi.org/10.1182/blood.V118.21.3609.3609

Published: 2011

Journal Articles

A Phase 1 Study of Concomitant High Dose Lenalidomide and 5-Azacytidine Induction in the Treatment of Acute Myeloid Leukemia,

Giridharan Ramsingh, MD, Peter Westervelt, MD, PhD, Amanda Cashen, MD, Geoffrey L. Uy, MD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD, Ryan Monahan, BA, CCRP, John F. DiPersio, MD, PhD, Ravi Vij, MD

Blood (2011) 118 (21): 3616.

https://doi.org/10.1182/blood.V118.21.3616.3616

Published: 2011

Journal Articles

Phase I Study of Intravenous Plerixafor Added to a Mobilization Regimen of G-CSF In Lymphoma Patients Undergoing Autologous Stem Cell Collection

Amanda Cashen, MD, Michael P. Rettig, PhD, Feng Gao, PhD, Camille N. Abboud, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD

Blood (2010) 116 (21): 823.

https://doi.org/10.1182/blood.V116.21.823.823

Published: 2010

Journal Articles

Decitabine for Older AML Patients: An Effective Therapy Associated with Short Hospitalization and No Invasive Fungal Infection.

George Ansstas, MD, Waseem Touma, MD, Camille Adeimy, MD, Gao Feng, Peter Westervelt, MD, PhD, Camille N. Abboud, MD, Geoffrey L. Uy, MD, Keith E. Stockerl-Goldstein, MD, Amanda Cashen, MD, John F. DiPersio, MD, PhD, Ravi Vij, MBBS, MD

Blood (2010) 116 (21): 1063.

https://doi.org/10.1182/blood.V116.21.1063.1063

Published: 2010

Journal Articles

A Retrospective Review of Response to Donor Leukocyte Infusions In Adults with Acute Myeloid Leukemia After Reduced Intensity Conditioned Allogeneic Hematopoietic Cell Transplantation.

Loretta Nastoupil, MD, Mark A. Schroeder, MD, Qin Zhang, MS, Uy Geoffrey, MD, Amanda Cashen, MD, Keith E. Stockerl-Goldstein, MD, Camille N. Abboud, MD, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Ravi Vij, MBBS, MD

Blood (2010) 116 (21): 4512.

https://doi.org/10.1182/blood.V116.21.4512.4512

Published: 2010

Journal Articles

Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T-Cell Lymphoma: A Single Center's 12-Year Experience

Hans C Lee, MD, Keith E. Stockerl-Goldstein, MD, Qin Zhang, MS, Amanda Cashen, MD

Blood (2010) 116 (21): 2360.

https://doi.org/10.1182/blood.V116.21.2360.2360

Published: 2010

Journal Articles

Bortezomib, Bendamustine, and Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma: Encouraging Activity in the Phase 2 VERTICAL Study.

Nathan Fowler, Brad S Kahl, Peter Rosen, Jeffrey Matous, Amanda Cashen, Samuel Jacobs, Jeffrey Letzer, Bipinkumar Amin, Michael Williams, Maureen Ross, Sonali Smith, Alfred Saleh, Hongliang Shi, Sudha Parasuraman, Bruce D. Cheson

Blood (2009) 114 (22): 933.

https://doi.org/10.1182/blood.V114.22.933.933

Published: 2009

Journal Articles

Poor Predictive Value of FDG-PET/CT Performed after 2 Cycles of R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLCL)

Amanda Cashen, M.D., Farrokh Dehdashti, M.D., Jingqin Luo, Ph.D., Nancy L. Bartlett, MD

Blood (2008) 112 (11): 371.

https://doi.org/10.1182/blood.V112.11.371.371

Published: 2008

Journal Articles

Tolerability of PTK787/ZK 222584 in a Phase II Study of Post-Transplant Maintenance Therapy in Patients with Multiple Myeloma Following High-Dose Chemotherapy and Autologous Stem Cell Transplant.

James C. Mosley, III, MD, Shachar Peles, M.D., Alisa Ruddell, B.A., Feng Gao, M.D., Ph.D., Camille Abboud, M.D., Amanda Cashen, M.D., Geoffrey Uy, M.D., Peter Westervelt, M.D., Ph.D., John F. DiPersio, M. D., Ph.D., Ravi Vij, M.D.

Blood (2007) 110 (11): 5109.

https://doi.org/10.1182/blood.V110.11.5109.5109

Published: 2007

Journal Articles

The Activity and Toxicity of Dasatinib in Relapsed or Plateau-Phase Multiple Myeloma.

Tanya M. Wildes, MD, Alisa Ruddell, B.A., Feng Gao, M.D., Ph.D., Geoffrey Uy, M.D., Amanda Cashen, M.D., Camille Abboud, M.D., Peter Westervelt, M.D., Ph.D., John F. Dipersio, M.D., Ph.D., Ravi Vij, M.D.

Blood (2007) 110 (11): 1182.

https://doi.org/10.1182/blood.V110.11.1182.1182

Published: 2007

Journal Articles

A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.

Richard Walgren, MD, PhD, Crystal Dao, MA, Frederieke Kreisel, MD, Peter Westervelt, MD, PhD, Camille Abboud, MD, Timothy Graubert, MD, Amanda Cashen, MD, Geoffrey Uy, MD, Feng Gao, MD, John DiPersio, MD, PhD, Ravi Vij, MD

Blood (2007) 110 (11): 1451.

https://doi.org/10.1182/blood.V110.11.1451.1451

Published: 2007

Journal Articles

Impact of Disease and Mobilizing Agents on Initial and Remobilization Failure.

John F. DiPersio, Angela Smith, Dianne Sempek, Albert Baker, Steven Jiang, Ravi Vij, Amanda Cashen, Peter Westervelt

Blood (2006) 108 (11): 5222.

https://doi.org/10.1182/blood.V108.11.5222.5222

Published: 2006

Journal Articles

Phase II Study of Low-Dose Decitabine for the Front-Line Treatment of Older Patients with Acute Myeloid Leukemia (AML).

Amanda Cashen, MD, Gary J. Schiller, MD, Julie S. Larsen, PharmD, Michael T. Cullen, Jr., MD, John F. DiPersio, MD, PhD

Blood (2006) 108 (11): 1984.

https://doi.org/10.1182/blood.V108.11.1984.1984

Published: 2006

Journal Articles

Kinetics of Autologous Stem Cell Mobilization Failure: Comparison of AMD3100/G-CSF, G-CSF, GM-/G-CSF, and Chemotherapy/G-CSF on Remobilization Success.

John F. DiPersio, Angela Smith, Dianne Sempek, Albert Baker, Steven Jiang, Ravi Vij, Amanda Cashen, Peter Westervelt

Blood (2006) 108 (11): 3380.

https://doi.org/10.1182/blood.V108.11.3380.3380

Published: 2006

NARROW

Outcomes of Primary Bone Diffuse Large B-Cell Lymphoma in the Rituximab Era: A Multicenter Retrospective Analysis

Quality of Life in Patients <=70 Years of Age with Chronic Lymphocytic Leukemia Treated Frontline with Ibrutinib-Rituximab Versus Fludarabine Cyclophosphamide Rituximab: Analysis from ECOG-ACRIN E1912

Results from the Phase 3 DUO TM Trial: A Randomized Comparison of Duvelisib Vs Ofatumumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

A Phase 2 Multicenter Study of Continuous Dose Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Defining the Malignant Epigenome in Non-Hodgkin Lymphoma

Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older with Acute Myeloid Leukemia,

Phase I Study of Cladribine (2-chlorodeoxyadenosie), Cytarabine and G-CSF Based Induction Therapy (CLAG) with ATRA (All-trans retinoic acid) and Midostaurin for Relapsed/Refractory AML,

A Phase 1 Study of Concomitant High Dose Lenalidomide and 5-Azacytidine Induction in the Treatment of Acute Myeloid Leukemia,

Phase I Study of Intravenous Plerixafor Added to a Mobilization Regimen of G-CSF In Lymphoma Patients Undergoing Autologous Stem Cell Collection

Decitabine for Older AML Patients: An Effective Therapy Associated with Short Hospitalization and No Invasive Fungal Infection.

A Retrospective Review of Response to Donor Leukocyte Infusions In Adults with Acute Myeloid Leukemia After Reduced Intensity Conditioned Allogeneic Hematopoietic Cell Transplantation.

Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T-Cell Lymphoma: A Single Center's 12-Year Experience

Bortezomib, Bendamustine, and Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma: Encouraging Activity in the Phase 2 VERTICAL Study.

Poor Predictive Value of FDG-PET/CT Performed after 2 Cycles of R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLCL)

Tolerability of PTK787/ZK 222584 in a Phase II Study of Post-Transplant Maintenance Therapy in Patients with Multiple Myeloma Following High-Dose Chemotherapy and Autologous Stem Cell Transplant.

The Activity and Toxicity of Dasatinib in Relapsed or Plateau-Phase Multiple Myeloma.

A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.

Impact of Disease and Mobilizing Agents on Initial and Remobilization Failure.

Phase II Study of Low-Dose Decitabine for the Front-Line Treatment of Older Patients with Acute Myeloid Leukemia (AML).

Kinetics of Autologous Stem Cell Mobilization Failure: Comparison of AMD3100/G-CSF, G-CSF, GM-/G-CSF, and Chemotherapy/G-CSF on Remobilization Success.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only